EPYSQLI
Eculizumab-aagh
- Strength
- 300 mg/30mL
- Form
- Injection, Solution
- Class
- Complement Inhibitor
Teva Pharmaceuticals USA, Inc.
Not stocked by us — reference only
eculizumab-aeeb
Listed by Amgen Inc
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Complement Inhibitor |
| Approval route | BLA — biologic licence |
| NDC code | 55513-180 |
| FDA application | BLA761333 |
| RxNorm concept | 2706351 |
| Package sizes listed | 1 |
| Marketed since | March 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Eculizumab-aagh
Teva Pharmaceuticals USA, Inc.
Not stocked by us — reference only
ECULIZUMAB
Alexion Pharmaceuticals Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.